Inovio Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
INO Inovio Pharmaceuticals Inc
VIVC Vivic Corp
BAC Bank of America Corp
DGRW WisdomTree U.S. Quality Dividend Growth Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DES WisdomTree U.S. SmallCap Dividend Fund
DEO Diageo PLC
DDF Delaware Investments Dividend and Income Fund
DAL Delta Air Lines Inc
Go

Health Care : Biotechnology | Mid Cap Blend
Company profile

Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

Premarket

Last Trade
Delayed
$21.25
0.32 (1.53%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$20.93
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
4,573

10-day average volume:
88,421,776
4,573

Thinking about buying stock in Capricor Therapeutics, Waitr, Takeda Pharmaceutical, Sorrento Therapeutics, or Inovio Pharmaceuticals?

9:31 am ET May 13, 2020 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for CAPR, WTRH, TAK, SRNE, and INO.

https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

-- CAPR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CAPR&prnumber=051320200

-- WTRH: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=WTRH&prnumber=051320200

-- TAK: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=TAK&prnumber=051320200

-- SRNE: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SRNE&prnumber=051320200

-- INO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=INO&prnumber=051320200

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

https://c212.net/c/img/favicon.png?sn=CG06573&sd=2020-05-13

View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-capricor-therapeutics-waitr-takeda-pharmaceutical-sorrento-therapeutics-or-inovio-pharmaceuticals-301058537.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG06573&Transmission_Id=202005130931PR_NEWS_USPR_____CG06573&DateId=20200513

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.